Connect your AI

Supernus Pharmaceuticals SUPN Price / book

Price / book at other companies

AbbVieABBV

261×+221×

Catalyst PharmaceuticalCPRX

3×-0.7×

Axsome TherapeuticsAXSM

158.4×+51.5×

Neurocrine BiosciencesNBIX

3.9×-0.5×

Jazz PharmaceuticalsJAZZ

2.6×+0.8×

Acadia PharmaceuticalsACAD

3×-0.6×

Other financials

Income statement

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Calculated from Supernus Pharmaceuticals’s reported figures.

market cap/total stockholders equity=2.8×

Based on the most recent quarter.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Supernus Pharmaceuticals's price / book?: Supernus Pharmaceuticals (SUPN) reported price / book of 2.8× in Q1 2026.
How has Supernus Pharmaceuticals's price / book changed year-over-year?: Supernus Pharmaceuticals's price / book increased by 55.9% year-over-year, from 1.8× to 2.8×.
What is the long-term trend for Supernus Pharmaceuticals's price / book?: Over 5 years (2020 to 2025), Supernus Pharmaceuticals's price / book has grown at a 8.5% compound annual growth rate (CAGR), from 1.8× to 2.7×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.